Millennium Management
FLGT icon

Millennium Management’s Fulgent Genetics FLGT Stock Holding History

Millennium Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,000
Closed -$1.45M – 6689
2021
Q1 		$1.45M Buy
+15,000
New +$1.55M ﹤0.01% 3838

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management's FLGT Position: Q1 2026 in Review

Millennium Management reduced its Fulgent Genetics (FLGT) stake by 57% in Q1 2026, selling an estimated $11.7M and leaving 401,819 shares worth $6.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

Millennium Management first reported a position in FLGT in Q3 2016 and has held it in 29 quarters since. The position peaked at $33.3M in Q1 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Millennium Management held 401,819 shares of Fulgent Genetics worth $6.39M as of Q1 2026.
  • Millennium Management sold 537,556 Fulgent Genetics shares in Q1 2026, an estimated $11.7M.
  • Fulgent Genetics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2669 holding.
  • Millennium Management first reported a position in Fulgent Genetics in Q3 2016 and has held it in 29 quarters since.
  • Millennium Management's Fulgent Genetics position peaked at $33.3M in Q1 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.